Adjuvant surgery following biological response modifier therapy extends survival in patients with metastatic renal cell carcinoma.

被引：0
|
作者：
Krishnamurthi, V
Novick, AC
Bukowski, R
机构：
来源：
JOURNAL OF UROLOGY | 1998年 / 159卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
763
引用
收藏
页码：198 / 198
页数：1
相关论文
共 50 条
  • [1] Patients perspectives on adjuvant therapy in renal cell carcinoma.
    Battle, Dena
    Jonasch, Eric
    Hammers, Hans J.
    Derweesh, Ithaar
    George, Daniel J.
    Bex, Axel
    Ljungberg, Borje
    Staehler, Michael D.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (06)
  • [2] Survival following upfront cytoreductive nephrectomy versus targeted therapy for metastatic renal cell carcinoma.
    Bhindi, Bimal
    Habermann, Elizabeth Butzer
    Mason, Ross
    Costello, Brian Addis
    Pagliaro, Lance C.
    Thompson, Robert Houston
    Leibovich, Bradley C.
    Boorjian, Stephen A.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (06)
  • [3] Adjuvant therapy for patients with renal cell carcinoma following surgery: a focus on pembrolizumab
    Serzan, Michael
    Atkins, Michael B.
    [J]. EXPERT REVIEW OF ANTICANCER THERAPY, 2022, 22 (06) : 565 - 574
  • [4] Treatment facility volume and survival in patients with metastatic renal cell carcinoma.
    Geynisman, Daniel M.
    Handorf, Elizabeth
    Zibelman, Matthew R.
    Plimack, Elizabeth R.
    Uzzo, Robert
    Kutikov, Alexander
    Smaldone, Marc C.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (06)
  • [5] Impact of statins and survival outcomes in patients with metastatic renal cell carcinoma.
    McKay, Rana R.
    Lin, Xun
    Albiges, Laurence K.
    Fay, Andre Poisl
    Kaymakcalan, Marina Dusevic
    Mickey, Suzanne S.
    Ghoroghchian, Paiman Peter
    Bhatt, Rupal Satish
    Simantov, Ronit
    Choueiri, Toni K.
    Heng, Daniel Yick Chin
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (07)
  • [6] Anxiety and patients: Perspectives on surveillance and adjuvant therapy in renal cell carcinoma.
    Battle, Dena
    Hammers, Hans J.
    Jonasch, Eric
    Derweesh, Ithaar
    George, Daniel J.
    Bex, Axel
    Ljungberg, Borje
    Staehler, Michael D.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [7] Nephrectomy status, race, and overall survival in patients with metastatic renal cell carcinoma.
    Robertson, Dale Kesley
    Zhang, Chao
    Liu, Yuan
    Gillespie, Theresa Wicklin
    Kucuk, Omer
    Carthon, Bradley Curtis
    Master, Viraj A.
    Issa, Muta
    Petros, John
    Harris, Wayne B.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (02)
  • [8] Efficacy of incomplete metastasectomy with targeted therapy in patients with metastatic renal cell carcinoma.
    Orlova, Rashida
    Borisov, Pavel
    Karlov, Petr A.
    Shkolnik, Michail
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [9] Treatment compliance in patients with metastatic renal cell carcinoma.
    Chen, C.
    Hess, G. P.
    Hill, J. W.
    Liu, Z.
    Agarwala, S. S.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [10] Endostatin neoadjuvant gene therapy extends survival in an orthotopic metastatic mouse model of renal cell carcinoma
    Braga, Marina de Souza
    Chaves, Karen Barbosa
    Chammas, Roger
    Schor, Nestor
    Bellini, Maria Helena
    [J]. BIOMEDICINE & PHARMACOTHERAPY, 2012, 66 (04) : 237 - 241
12345